Successful progress of Covid-19 vaccine invented in Bangladesh
Published: 02:36 PM, 2 July 2020 Updated: 08:48 PM, 2 July 2020
Officials of Globe Biotech Limited have reported the successful progress of their invented vaccine for the coronavirus, claiming that “the vaccine was able to produce antibodies in the initial animal trial.”
They made the claim at a press conference at the company’s office in Tejgaon in the capital on Thursday.
“The vaccine will be tested in the second phase,” the press conference said.
It will take six to eight weeks. If successful at this stage, it will be clinical trials on the human body, the officials said, adding that the government authority’s permission will be taken. “If they get permission, they will go to the trial.”
Dr. Asif Mahmud, head of the Resources and Development Department of Globe Biotech Limited, said, “Actually, we were initially successful with it after we started work. It was successful in the animal model. Now we hope it works successfully in the human body.”
We will now go to the concerned offices of the government. Then we’ll complete the next phases as per the guidelines they provide, he added.
Earlier, on Wednesday, the company claimed that they had succeeded in vaccine development on animal bodies. They hope that it can be successful in the human body too.
According to the NCBI virus database, 5,743 complete genome sequences have been submitted worldwide as of Tuesday. 76 of those have been collected from Bangladesh, the company said in a press release.
Globe Biotech Limited confirmed their vaccine target by testing the sequence through the Bioinformatics tool. They are hoping that this geographical area will be more effective in a reasonable way.